Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masahisa Jinushi, Yukoh Nakazaki, Michael Dougan, Daniel R. Carrasco, Martin Mihm, Glenn Dranoff
Published in Volume 117, Issue 7
J Clin Invest. 2007; 117(7):1902–1913 doi:10.1172/JCI30966
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 7
MFG-E8 expression is downregulated upon antigen-presenting cell maturation.

(A) Wild-type peritoneal macrophages were exposed to apoptotic cells and peptidoglycan (TLR2), poly-IC (TLR3), LPS (TLR4), or CpG (TLR9), and MFG-E8 expression was determined. Numbers refer to the percentage of cells within an indicated gate. (B) Engineered wild-type peritoneal macrophages were exposed to apoptotic cells with or without LPS, and supernatants were assayed by ELISA. (C) Transduced peritoneal macrophages were exposed to apoptotic cells with or without LPS and cocultured with allogeneic Balb/c splenocytes. Proliferation was determined by 3H-thymidine uptake. (D) Flt3-L– or GM-CSF–derived bone marrow dendritic cells were assayed for B220 and MFG-E8 expression. LPS or freeze-thaw–induced necrotic cells were added where indicated. (E) Flt3-L–derived dendritic cells were sorted into B220+ and B220 populations, exposed to apoptotic or necrotic cells, and assayed for cytokine production by ELISA. Similar results were obtained in at least 2 independent experiments. –, no TLR agonist added.